# Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

> **NCT00014430** · PHASE1 · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** trastuzumab
- **DRUG:** vinorelbine ditartrate

## Key facts

- **NCT ID:** NCT00014430
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2002-09
- **Final completion:** —
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014430, "Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00014430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*